Details
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Xoople $130M Series BPLD Space €180M Series CRanked by rounds participated in, from announcements in Jan 1, 2026 – Oct 26, 2026. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Xoople $130M Series BPLD Space €180M Series CNew companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Hybron Technologies $20M SeedCambium $100M Series BNew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Syneron Bio $150M Series BEarendil Labs Undisclosed Financing rounds disclosureNew companies 2 · Follow-on 0
Stages: Series C+ 2
Saronic Technologies $1.8B Series DShield AI $1.5B Series GNew companies 2 · Follow-on 0
Stages: Series B 2
Ambrosia Biosciences $100M Series BMirador Therapeutics $250M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Ambrosia Biosciences $100M Series BRapidFort $42M Series ANew companies 2 · Follow-on 0
Stages: Series B 2
Ambrosia Biosciences $100M Series BCrossbow Therapeutics $77M Series BNew companies 2 · Follow-on 0
Stages: Pre-seed 1, Series A 1
Sub-Q Bionics $1.5M Pre-SeedScala Biodesign $16M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Kandou AI $225M Series ASkild AI $1.4B UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
KilgourMD Undisclosed Series ACartwheel $35.2M Series BNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Shield AI $1.5B Series GFreeform $67M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Giraffe360 $10M Series BSaltz €20M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Xona $170M Series CArmorCode $16M Series BNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
PAVE Space $40M SeedCellbricks Therapeutics €10M Seed+Non-DilutiveNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Pro Padel League $15M Series ASlips $3.5M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Cauldron Ferm $13.3M Series A2Alpaca $150M Series DNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Foreverland €6M Series BUBEES €8M Series ANew companies 2 · Follow-on 0
Stages: Series B 2
Congruence Therapeutics $39.5M Series BMediar Therapeutics $76M Series B“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.